ClinicalTrials.govpublic full text
Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
primary peritoneal carcinoma, recurrent ovarian carcinoma, stage iv ovarian cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855145
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.